Safety and Efficacy Study in Infant With SBS
Clinical trial NCT02865122 · TERMINATED
Trial details
- NCT number
- NCT02865122
- Sponsor
- Elgan Pharma Ltd.
- Status
- TERMINATED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-20
- Primary completion
- 2018-03-22
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.